John H. Suh

Active 1997–2025

111
Papers
17,951
Citations
70
h-index
106
i10-index

Citations

Citations per year for John H. Suh1993: 2 citations1998: 4 citations1999: 8 citations2000: 6 citations2001: 9 citations2002: 23 citations2003: 30 citations2004: 51 citations2005: 59 citations2006: 53 citations2007: 66 citations2008: 63 citations2009: 66 citations2010: 68 citations2011: 77 citations2012: 84 citations2013: 114 citations2014: 131 citations2015: 99 citations2016: 172 citations2017: 147 citations2018: 133 citations2019: 469 citations2020: 612 citations2021: 511 citations2022: 371 citations2023: 290 citations2024: 522 citations2025: 222 citations2026: 6 citations1994–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,727 citing papers, 31.3% of this breakdownGermany: 372 citing papers, 6.7% of this breakdownChina: 356 citing papers, 6.4% of this breakdownCanada: 333 citing papers, 6% of this breakdownItaly: 305 citing papers, 5.5% of this breakdownNetherlands: 249 citing papers, 4.5% of this breakdownFrance: 241 citing papers, 4.4% of this breakdownUnited Kingdom: 233 citing papers, 4.2% of this breakdownSwitzerland: 200 citing papers, 3.6% of this breakdownJapan: 148 citing papers, 2.7% of this breakdownSpain: 129 citing papers, 2.3% of this breakdownAustria: 114 citing papers, 2.1% of this breakdown
0%31.3%Other 20.3%

Fields

  • Medicine90.2%
  • Biochemistry, Genetics and Molecular Biology4.6%
  • Physics and Astronomy1.4%
  • Neuroscience1.2%
  • Engineering1%
  • Materials Science0.4%
  • Other1.2%

Topics

  • Brain Metastases and Treatment17.9%
  • Glioma Diagnosis and Treatment14%
  • Lung Cancer Research Studies7.5%
  • Meningioma and schwannoma management4.7%
  • Lung Cancer Treatments and Mutations3.8%
  • Management of metastatic bone disease3.7%
  • Other48.4%

Coauthors

All papers

Open in search
  1. Response assessment criteria for brain metastases: proposal from the RANO group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 cited by 1,088

  2. Current approaches to the management of brain metastases

    Authors: , , , , , - Nature Reviews Clinical Oncology 2020 cited by 551

  3. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2016 cited by 1,044

  4. Radiation Therapy for Brain Metastases: An ASTRO Clinical Practice Guideline

    Authors: , , , , , , , , , , , , , , , , , , , - Practical Radiation Oncology 2022 cited by 376

  5. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

    Authors: , , , , , , , , , , , , , , - Neuro-Oncology 2013 cited by 944

  6. Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2011 cited by 1,420

  7. Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

    Authors: , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2009 cited by 985

  8. A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society Recommendations

    Authors: , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2023 cited by 84

  9. Vertebral Compression Fracture After Spine Stereotactic Body Radiotherapy: A Multi-Institutional Analysis With a Focus on Radiation Dose and the Spinal Instability Neoplastic Score

    Authors: , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 389

  10. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis

    Authors: , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2016 cited by 166

  11. Challenges With the Diagnosis and Treatment of Cerebral Radiation Necrosis

    Authors: , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2013 cited by 312

  12. Randomized Trial of Short- Versus Long-Course Radiotherapy for Palliation of Painful Bone Metastases

    Authors: , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2005 cited by 828

  13. The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases

    Authors: , , , , - Neuro-Oncology 2024 cited by 57

  14. The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies

    Authors: , , , , , , , , , , , , , , , - Journal of Neuro-Oncology 2017 cited by 142

  15. Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study

    Authors: , , , , , , , , , , , , , - Journal of Neuro-Oncology 2016 cited by 93

  16. Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines

    Authors: , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2021 cited by 79

  17. Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis

    Authors: , , , , , , , , , , , - Journal of Neuro-Oncology 2023 cited by 46

  18. Effect of Tumor Subtype on Survival and the Graded Prognostic Assessment for Patients With Breast Cancer and Brain Metastases

    Authors: , , , , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2011 cited by 375

  19. Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme

    Authors: , , , , , , , , , , , - Journal of Neuro-Oncology 2009 cited by 199

  20. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm

    Authors: , , , , , , , , , , , , , - Journal of neurosurgery 2017 cited by 119

  21. The impact of sequencing PD-1/PD-L1 inhibitors and stereotactic radiosurgery for patients with brain metastasis

    Authors: , , , , , , , , , , , , - Neuro-Oncology 2019 cited by 115

  22. Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion

    Authors: , , , , , , , , , , , , - Neuro-Oncology 2019 cited by 95

  23. Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations

    Authors: , , , , , , , , , , , , , - Journal of neurosurgery 2021 cited by 60

  24. Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases

    Authors: , , , , , , , , , , , , , , - Scientific Reports 2021 cited by 35